Cargando…

Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment

Detalles Bibliográficos
Autores principales:	Grabenstetter, Anne, Lazaro, Conxi, Turashvili, Gulisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738629/ https://www.ncbi.nlm.nih.gov/pubmed/33344261 http://dx.doi.org/10.3389/fonc.2020.618369

Ejemplares similares

Pathology of Hereditary Breast and Ovarian Cancer
por: Hodgson, Anjelica, et al.
Publicado: (2020)

Tumor Heterogeneity in Breast Cancer
por: Turashvili, Gulisa, et al.
Publicado: (2017)

Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?
por: Strickland, Sarah, et al.
Publicado: (2022)

ADNP (Activity Dependent Neuroprotector Homeobox): A novel oncogene driving poor prognosis in high-grade serous carcinoma
por: Turashvili, Gulisa
Publicado: (2020)

SEOM clinical guidelines in Hereditary Breast and ovarian cancer
por: Llort, G., et al.
Publicado: (2015)

Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach
por: Oliver, Javier, et al.
Publicado: (2019)

What’s new in gynecologic pathology 2021: ovary and fallopian tube
por: Turashvili, Gulisa, et al.
Publicado: (2021)

Tumor BRCA Testing in High Grade Serous Carcinoma: Mutation Rates and Optimal Tissue Requirements
por: Turashvili, Gulisa, et al.
Publicado: (2020)

Editorial: Update of Current Evidences in Breast Cancer Surgery
por: Franceschini, Gianluca, et al.
Publicado: (2022)

TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
por: Grill, Sabine, et al.
Publicado: (2020)

Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening
por: Kadri, Mohammed Shaad N., et al.
Publicado: (2021)

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
por: Narod, Steven
Publicado: (2004)

Hereditary breast and ovarian cancer
por: Gronwald, Jacek, et al.
Publicado: (2008)

BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort
por: Rofes, Paula, et al.
Publicado: (2021)

Editorial: Impact of Breast MRI on Breast Cancer Treatment and Prognosis
por: Bitencourt, Almir, et al.
Publicado: (2022)

Editorial: Cancer prevention, treatment and survivorship in the LGBTQIA community
por: Ussher, Jane M., et al.
Publicado: (2023)

Hereditary Angioedema: Diagnostic Algorithm and Current Treatment Concepts
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes
por: Carnevali, Ileana, et al.
Publicado: (2022)

Editorial: Hereditary Cancer Risk Assessment: New Perspectives and Challenges for the Next-Gen Sequencing Era
por: Gomy, Israel
Publicado: (2016)

The Ethnic-Specific Spectrum of Germline Nucleotide Variants in DNA Damage Response and Repair Genes in Hereditary Breast and Ovarian Cancer Patients of Tatar Descent
por: Brovkina, Olga I., et al.
Publicado: (2018)

Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center
por: Zang, Benedikt, et al.
Publicado: (2022)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Tolba, Mai F., et al.
Publicado: (2021)

Editorial: Treatment for advanced breast cancer with brain metastases
por: Yan, Min, et al.
Publicado: (2023)

Genetic and Preventive Services for Hereditary Breast and Ovarian Cancer in the Czech Republic
por: Foretova, Lenka, et al.
Publicado: (2006)

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
por: Blanchette, Phillip, et al.
Publicado: (2022)

Editorial: Novel targets for ovarian cancer stem cells
por: Wang, Yinu, et al.
Publicado: (2023)

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
por: Hendriks, Lizza E. L., et al.
Publicado: (2018)

Editorial: Reviews in breast cancer
por: De Miglio, Maria Rosaria, et al.
Publicado: (2023)

Editorial: Methods in breast cancer
por: Franceschini, Gianluca
Publicado: (2023)

Editorial: Cancer Metabolism: Current Knowledge and Perspectives
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2019)

Editorial: Disparities in Cancer Prevention and Epidemiology
por: Montazeri, Fateme, et al.
Publicado: (2022)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
por: Megid, Thais Baccili Cury, et al.
Publicado: (2022)

Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)

Advocate's Viewpoint on Hereditary Breast/Ovarian Cancer
por: Kolling-Dandrieu, Francisca Bach
Publicado: (2004)

Educational Case: Hereditary breast and ovarian cancers
por: Givi, Jerome P., et al.
Publicado: (2023)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Women in breast cancer: 2021
por: Provenzano, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6f5bq2lvb30obo8jmmrmmdajln